Mark A Prygocki Sr

Mark A Prygocki Sr has an estimated net worth of $20 Million. This is based on reported shares across multiple companies, which include Revance Therapeutics, Inc., Verrica Pharmaceuticals Inc., Clarus Therapeutics Holdings, Inc., and MEDICIS PHARMACEUTICAL CORP.

2004 was Mark A Prygocki Sr's most active year for acquiring shares with 12 total transactions. Mark A Prygocki Sr's most active month to acquire stocks was the month of June. 2004 was Mark A Prygocki Sr's most active year for disposing of shares, totalling 19 transactions. Mark A Prygocki Sr's most active month to dispose stocks was the month of January. 2011 saw Mark A Prygocki Sr paying a total of $1,821,577.45 for 115,468 shares, this is the most they've acquired in one year. In 2012 Mark A Prygocki Sr cashed out on 526,704 shares for a total of $16,092,743.74, their largest year based on trade value.